PHARMACOKINETICS OF 4'EPI-DOXORUBICIN AFTER INTRAVENOUS AND INTRAVESICAL ADMINISTRATION

被引：0
|
作者：
VANDERVIJGH, WJF
WEENEN, H
OSTEROP, A
VANDERPOORT, SEJM
KURTH, KK
BOGDANOWICZ, JF
PINEDO, HM
机构：
[1] FREE UNIV HOSP AMSTERDAM,DEPT ONCOL,1081 HV AMSTERDAM,NETHERLANDS
[2] ERASMUS UNIV,DEPT UROL,3000 DR ROTTERDAM,NETHERLANDS
来源：
BRITISH JOURNAL OF CANCER | 1985年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：463 / 464
页数：2
相关论文
共 50 条
  • [1] ABSORPTION OF EPI-DOXORUBICIN AFTER INTRAVESICAL ADMINISTRATION IN PATIENTS WITH INSITU TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    MROSS, K
    MAESSEN, P
    VANDERVIJGH, WJF
    BOGDANOWICZ, JF
    KURTH, KH
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (05): : 505 - 508
  • [2] PHARMACOKINETICS AND CENTRAL HEMODYNAMIC-EFFECTS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN THE PIG
    ANDERSSON, M
    DOMELLOF, L
    EKSBORG, S
    HAGGMARK, S
    JOHANSSON, G
    REIZ, S
    HERSLOF, A
    ACTA ONCOLOGICA, 1989, 28 (05) : 709 - 714
  • [3] INTRAVESICAL CHEMORESECTION WITH 4'-EPI-DOXORUBICIN IN PATIENTS WITH SUPERFICIAL BLADDER-TUMORS
    DASILVA, FC
    DENIS, L
    BONO, A
    BOLLACK, C
    BOUFFIOUX, C
    EUROPEAN UROLOGY, 1988, 14 (03) : 207 - 209
  • [4] DOXORUBICIN (DXR) AND 4'-EPI-DOXORUBICIN (4EDXR) - CLINICAL-EXPERIENCE AND PHARMACOKINETICS
    MARTONI, A
    DIMARCO, AR
    CAMAGGI, CM
    STROCCHI, E
    FRUET, F
    MARRARO, D
    GIOVANNINI, M
    TOMASI, L
    PACCIARINI, MA
    PANNUTI, F
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1983, 9 (11) : 767 - 774
  • [5] COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA
    TIDEFELT, U
    SUNDMANENGBERG, B
    PAUL, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (04) : 225 - 229
  • [6] CROSSOVER STUDY OF PHARMACOKINETICS AND HEMATOLOGICAL TOXICITY OF 4'-EPI-DOXORUBICIN AND DOXORUBICIN IN CANCER-PATIENTS
    MARTINI, A
    MORO, E
    PACCIARINI, MA
    TAMASSIA, V
    NATALE, N
    PIAZZA, E
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1984, 4 (03) : 231 - 238
  • [7] TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN
    BONFANTE, V
    VILLANI, F
    BONADONNA, G
    TUMORI JOURNAL, 1982, 68 (02): : 105 - 111
  • [8] PHARMACOKINETICS OF EPI-DOXORUBICIN AND DOXORUBICIN IN BREAST-CANCER PATIENTS - A CROSSOVER STUDY
    MROSS, K
    MAESSEN, P
    VANDERVIJGH, WJF
    GALL, H
    BOVEN, E
    PINEDO, HM
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 114 - 114
  • [9] CLINICAL TOXICITY OF 4'-EPI-DOXORUBICIN (EPIRUBICIN)
    GANZINA, F
    DIPIETRO, N
    MAGNI, O
    TUMORI, 1985, 71 (03) : 233 - 240
  • [10] DISTRIBUTION OF 4'EPI-DOXORUBICIN IN HUMAN-TISSUES
    ITALIA, C
    PAGLIA, L
    TRABATTONI, A
    LUCHINI, S
    VILLAS, F
    BERETTA, L
    MARELLI, G
    NATALE, N
    BRITISH JOURNAL OF CANCER, 1983, 47 (04) : 545 - 547
12345